Bill Details
HRES.277 - 119th Congress
Status
Latest action
2025-03-31 - Referred to the House Committee on Energy and Commerce.
Introduced Date
2025-03-31
Policy Area
Health
Committees
View committees (1)
Cosponsors
View cosponsors (2)
6
0
0
AI Summary This summary was generated by AI from the bill text. AI can get information wrong.
This resolution supports recognizing May 2025 as a month to raise awareness about myositis, a group of rare autoimmune diseases that cause muscle inflammation, weakness, pain, fatigue, and other serious health problems. It says more people need to understand these conditions because they are often hard to diagnose, treatment is often delayed, and many patients face a lower quality of life. The resolution also encourages more research and public support for people and families living with these diseases.
- Myositis is a rare, long-lasting disease that can damage muscles and may also affect the lungs and swallowing.
- The resolution says there is still no cure, and more research is needed to find better causes and treatments.
- It notes that some people, including women and people of color, face greater health gaps and worse outcomes.
- Congress encourages people in the United States to learn more about myositis and support those affected by it.
Official Summaries
No summaries available
Current Full Text
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 277 Introduced in House (IH)]
<DOC>
119th CONGRESS
1st Session
H. RES. 277
Supporting the designation of May 2025 as ``National Myositis Awareness
Month''.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
March 31, 2025
Mr. McCormick submitted the following resolution; which was referred to
the Committee on Energy and Commerce
_______________________________________________________________________
RESOLUTION
Supporting the designation of May 2025 as ``National Myositis Awareness
Month''.
Whereas residents of the United States of America are among those affected by
myositis and other rare diseases, with nearly 1 in 10 Americans having
rare diseases;
Whereas idiopathic inflammatory myopathies (collectively referred to as
myositis) are rare, chronic, autoimmune muscle-wasting diseases that
often feature debilitating muscle inflammation and other symptoms, such
as pain, fatigue, and trouble swallowing, and can result in myositis-
associated interstitial lung disease;
Whereas more research is needed to identify the causes of and modes of
treatments for the myositis group of diseases, which includes anti-MDA5
autoantibody-positive myositis, antisynthetase syndrome,
dermatomyositis, juvenile dermatomyositis, immune-mediated necrotizing
myopathy, inclusion body myositis, and polymyositis;
Whereas myositis is difficult to diagnose which leads myositis patients to
frequently experience delayed treatment and difficulty finding a health
care provider with expertise in their condition;
Whereas all who suffer with myositis experience reduced quality of life,
particularly since no cure has been found and life expectancy is
shortened, especially for those with inclusion body myositis, and women
and people of color with all forms of myositis experience particularly
pronounced health disparities; and
Whereas public awareness and education campaigns on myositis detection and
treatment are held during the month of May: Now, therefore, be it
Resolved, That the House of Representatives--
(1) supports the designation of ``National Myositis
Awareness Month'';
(2) recognizes the importance of raising awareness about
myositis and its impact on United States veterans and citizens;
and
(3) encourages all people in the United States to become
more informed about myositis and to support the individuals and
families who are affected by these conditions.
<all>